Homocysteine and folate levels as risk factors for recurrent early pregnancy loss

Obstetrics and Gynecology

Volumn 95, Issue 4, 2000, Pages 519-524

  Nelen, Willianne L D M ^a   Blom, Henk J ^a   Steegers, Eric A P ^a   Den Heijer, Martin ^a   Thomas, Chris M G ^a   Eskes, Tom K A B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; FOLIC ACID BLOOD LEVEL; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR;

ABORTION, HABITUAL; ADULT; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; ODDS RATIO; PREGNANCY; RISK;

EID: 0034008262     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00610-9     Document Type: Article

References (21)

1. Thiersch J.B. Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A.) administered by the oral route. Am J Obstet Gynecol. 63:1952;1298-1304.
2. Hibbard B.M. The role of folic acid in pregnancy. With particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Brit Cwlth. 71:1964;529-542.
3. Martin RH, Harper TA, Kelso W. Serum-folic-acid in recurrent abortions. Lancet 1965;670-2.
4. Friedman S., Shachter A., Eckerling B., Eichhorn F., Rutenberg A. Formino-glutamic acid (Figlu) excretion and abortion. Panminerva Med. 19:1977;271-274.
5. Dutta G.P. Serum folic level in abortion. J Indian Med Assoc. 69:1977;149-153.
6. Pietrzik K., Prinz R., Reusch K., Bung P., Mallmann P., Chronides A. Folate status and pregnancy outcome. Ann N Y Acad Sci. 669:1992;371-373.
7. Wouters M.G.A.J., Boers G.H.J., Blom H.J., Trijbels F.J.M., Thomas C.M.G., Borm G.F., et al. Hyperhomocysteinemia A risk factor in women with unexplained recurrent early pregnancy loss . Fertil Steril. 60:1993;820-825.
8. Sutterlin M., Bussen S., Ruppert D., Steck T. Serum levels of folate and cobalamin in women with recurrent spontaneous abortion. Hum Reprod. 12:1997;2292-2296.
9. Steegers-Theunissen R.P.M., Boers G.H.J., Blom H.J., Trijbels F.J.M., Eskes T.K.A.B. Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae. Lancet. 339:1992;1122-1123.
10. Quere I., Bellet H., Hoffet M., Janbon C., Mares P., Gris J.C. A woman with five consecutive fetal deaths Case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages . Fertil Steril. 69:1998;152-154.
11. Coumans A.B.C., Huijgens P.C., Jakobs C., Schats R., De Vries J.I.P., van Pampus M.G., et al. Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion. Hum Reprod. 14:1999;211-214.
12. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattström L.E., Ueland P.M., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 277:1997;1775-1781.
13. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease Probable benefits of increasing folic acid intakes . J Am Med Assoc. 274:1995;1049-1057.
14. Nelen W.L.D.M., Steegers E.A.P., Eskes T.K.A.B., Blom H.J. Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet. 350:1997;861.
15. Nelen W.L.D.M., Van der Molen E.F., Blom H.J., Heil S.G., Steegers E.A.P., Eskes T.K.A.B. Recurrent early pregnancy loss and genetic-related disturbances in folate and homocysteine metabolism. Br J Hosp Med. 58:1997;511-513.
16. Nelen W.L.D.M., Blom H.J., Thomas C.M.G., Steegers E.A.P., Boers G.H.J., Eskes T.K.A.B. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr. 128:1998;1336-1341.
17. Use of folic acid-containing supplements among women of childbearing age - United States, 1997. JAMA. 279:1998;1430.
18. de Walle H.E., De Jong-Van den Berg L.T., Cornel M.C. Periconceptional folic acid intake in the northern Netherlands. Lancet. 353:1999;1187.
19. Clark N.A., Fisk N.M. Minimal compliance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br J Obstet Gynaecol. 101:1994;709-710.
20. Habibzadeh N., Schorah C.J., Smithells R.W. The effects of maternal folic acid and vitamin C nutrition in early pregnancy on reproductive performance in the guinea-pig. Br J Nutr. 55:1986;23-35.
21. Tremblay G.F., Matte J.J., Dufour J.J., Brisson G.J. Survival rate and development of fetuses during the first 30 days of gestation after folic acid addition to a swine diet. J Anim Sci. 67:1989;724-732.